Versions Compared

Old Version 355

changes.mady.by.user Former WMDA staff member

Saved on

compared with

New Version Current

changes.mady.by.user Jitske Barneveld

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Image Added

Panel
borderColor#00acc8
titleColor#FFFFFF
titleBGColor#00acc8
titleContact WMDA
Wmda button red
buttontextReport incident/crisis
buttonlinkhttps://share.wmda.info/x/dQAOEw


 Wmdabutton
buttontextContact the WMDA Office
buttonlinkmailto: mail@wmda.info

 Panel
borderColor#00acc8
titleColor#FFFFFF
titleBGColor#00acc8
titleWMDA information
 Wmda button red
buttontextGet familiar with WMDA Share
buttonlinkhttps://share.wmda.info/x/5wAOEw


 Wmda button red
buttontextGlobal Trends Report 2023
buttonlinkhttps://share.wmda.info/x/iAinGw


 Wmda button red
buttontextSPEAR Report 2022
buttonlinkhttps://share.wmda.info/x/S4tOGg


 Wmda button red
buttontextWMDA media centre
buttonlinkhttps://wmda.info/about-us/media-centre/
Image Removed
Coronavirus (2019-nCoV)
A novel coronavirus (currently named 2019-nCoV) emerged in Wuhan, China in December 2019.  WHO declared a global health emergency on 30 January 2020, and a number of blood and tissue donor guidelines have been issued - largely based on previous guidelines for SARS-CoV and MERS-CoV. Like SARS and MERS, 2019-nCoV displayed high mortality but low infectivity in the early weeks, with limited person-to-person transmission.  However, the epidemic quickly changed to display lower mortality but higher infectivity with increasing evidence of sustained person-to-person transmission. Various public health measures taken at a local or national level are likely to aid and/or complicate donor assessment, while the rapid evolution of the epidemic demands a precautionary yet flexible approach to suitability guidelines.
Image Removed
Read more here:
  • Coronavirus - 2019-nCoV recommendation from donor suitability committee
    • Information from registries whose operations are impacted by Coronavirus
    How to work on WMDA Share?x/5wAOEw


     Wmda button red
    buttontext
    Organisation Closure Agenda
    buttonlinkhttps://share.wmda.info/
    display/WMDAREG/Organisation+closure+agenda
     Panel
    borderColor#00Acc8#BE1E2A
    titleColorwhite
    borderWidth1
    titleBGColor#BE1E2A
    titleCommunication to members
    Update yourself on the latest news and read Stem Cell Matters, our monthly newsletter.

     Wmdabutton
    buttontextStem Cell Matters
    buttonlinkhttps://share.wmda.info/x/-BYjF


     Wmdabutton
    buttontextBlog post Pillar updates
    buttonlinkhttps://share.wmda.info/x/IA-UGg
     Panel
    borderColor#BE1E2A
    titleColor#FFFFFF
    titleBGColor
    #00Acc8
    #BE1E2A
    titleWMDA 
     Share support
    Image Removed
    In need of help? Question or suggestion? 
    Drop a note by e-mail tomail@wmda.info.
    important news updates
    Read the most important updates from the WMDA office and notifications to support global collaboration.
    Information for Human Cell, Tissue, and Cellular and Tissue-Based Product (HCT/P) - Establishments Regarding FDA's Determination that Zika Virus is no Longer a Relevant Communicable Disease Agent or Disease
    On the morning of May 21, 2024, the FDA announced that Zika Virus is no longer a relevant communicable disease agent or disease for HCT/Ps. As such, screening for risk of Zika Virus will no longer be required for cord blood donors, cord blood banking, or for manufacturing of cellular therapies derived from cord blood or birthing tissues. Travel to areas of the world where Zika Virus previously occurred will no longer be an exclusion for cord blood banking or for cord blood licensure. The change went into effect yesterday, May 20, 2024. Find here more information, click here.
    -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
    REDOME Survey
    Please help the Brazilian Bone Marrow Donor Registry, REDOME, by filling out their survey: here. 
    Redome has initiated a research plan to evaluate REDOME as part of Brazilian public policy for unrelated hematopoietic stem cell transplants, compared to other international registries. The research's main focus is on sustainability and some financial data are fundamental to performing economic analysis. 
    -------------------------------------------------------------------------------------------------------------------------
    WMDA strongly condemns the violence that is occurring in Ukraine, Israel and Gaza. We offer our sympathies to all those who are suffering because of these conflicts. We extend our support to the donor registries and medical centres whose donors and patients are negatively affected by these crises. 
    -------------------------------------------------------------------------------------------------------------------------
     Panel
    borderColor#BE1E2A
    titleColor#FFFFFF
    titleBGColor#BE1E2A

                  Image Added